Effects of heat exposure in a Finnish sauna on the pharmacokinetics and metabolism of midazolam

European Journal of Clinical Pharmacology

Volumn 51, Issue 3-4, 1996, Pages 335-338

  Vanakoski, J ^a,b   Idanpaan Heikkila J J ^a   Olkkola, K T ^c   Seppala T ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

heat; midazolam; pharmacodynamics; pharmacokinetics; sauna; metabolism

Indexed keywords

DRUG METABOLITE; MIDAZOLAM; MIDAZOLAM MALEATE;

ADULT; AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG METABOLISM; FINLAND; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; SAUNA; THERMAL EXPOSURE; VOLUNTEER;

ADULT; CROSS-OVER STUDIES; HEAT; HUMANS; LIVER; LIVER CIRCULATION; MALE; MIDAZOLAM;

EID: 0030444748     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050208     Document Type: Article

References (19)

1. Vanakoski J, Strömberg C, Seppälä T (1993) Effects of a sauna on the pharmacokinetics and pharmacodynamics of midazolam and ephedrine in healthy young women. Eur J Clin Pharmacol 45:377-381
2. Vanakoski J, Seppälä T (1995) Effects of a Finnish sauna on the pharmacokinetics and haemodynamic actions of propranolol and captopril in healthy volunteers. Eur J Clin Pharmacol 48:133-137
3. Kauppinen K, Vuori I (1986) Man in the sauna. Ann Clin Res 18:173-185
4. van Baak M (1990) Influence of exercise on the pharmacokinetics of drugs. Clin Pharmacokinet 19:32-43
5. Smith MT, Eadie MJ, O'Rourke Brophy T (1981) The pharmacokinetics of midazolam in man. Eur J Clin Pharmacol 19:271-278
6. Heizmann P, Eckert M, Ziegler WH (1983) Pharmacokinetics and bioavailability of midazolam in man. Br J Clin Pharmacol 16:43S-49S
7. Thummel KE, Shen DD, Podoll TD, Kunze KL, Trager WF, Hartwell PS, Raisys VA, Marsh CL, McVicar JP, Barr DM, Perkins JD, Carithers RL Jr, (1994) Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients. J Pharmacol Exp Ther 271:549-556
8. Lown KS, Thummel KE, Benedict PE, Shen DD, Turgeon DK, Berent S, Watkins PB (1995) The erythromycin breath test predicts the clearance of midazolam. Clin Pharmacol Ther 57:16-24
9. Pentikäinen PJ, Välisalmi L, Himberg JJ, Crevoisier C (1989) Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease. J Clin Pharmacol 29:272-277
10. Wilkinson L (1988) Systat: the system for statistics. Evanston, IL, Systat
11. Gabrielsson J, Weiner D (1994) Pharmacokinetic and pharmacodynamic data analysis. Swedish Pharmaceutical Press, Stockholm, Sweden
12. Akaike H. An information criterion (AIC) (1976) Math Sci 14:5-9
13. Rowland M, Tozer TN (1989) Clinical pharmacokinetics. Concepts and applications, 2nd edn. Lea & Febiger, Philadelphia, USA
14. Perrier D, Meyersohn M (1982) Noncompartmental determination of the steady-state volume of distribution for any mode of administration. J Pharm Sci 71:372-373
15. Kuitunen T, Mattila MJ, Seppälä T (1990) Actions and interactions of hypnotics on human performance: Single doses of zopiclone, triazolam and alcohol. Int Clin Psychopharmacol 55[Suppl 2]:115-130
16. Allonen H, Ziegler G, Klotz U (1981) Midazolam kinetics. Clin Pharmacol Ther 30:653-661
17. Vanakoski J, Idänpään-Heikkilä JJ, Seppälä T (1996) Exposure to high environmental temperature in the sauna does not change plasma indocyanine green (ICG) clearance in healthy subjects. Pharmacol Toxicol 78:94-98
18. Holazo AA, Winkler MB, Patel IH (1988) Effects of age, gender and oral contraceptives on intramuscular midazolam pharmacokinetics. J Clin Pharmacol 28:1040-1045
19. Kukkonen-Harjula K, Oja P, Laustiola K, Vuori I, Jolkkonen J. Siitonen S, Vapaataloh H (1989) Haemodynamic and hormonal responses to heat exposure in a Finnish sauna bath. Eur J Appl Physiol 58:543-550